WASHINGTON (AP) - Federal health officials are warning an HIV drug comes with the risk of a rare, but potentially deadly liver disorder.
The Food and Drug Administration says it has received more than 40 reports of the disorder since Bristol-Myers Squibb's Videx was approved in 1991. Four patients died from bleeding or liver failure after developing the problem.
The issue arises when there is dangerously slow blood flow through the liver, which can cause veins in the esophagus to burst.
The FDA says it's keeping Videx on the market, because its benefits outweigh the risks. The drug prevents HIV from multiplying.
New labeling on Videx says patients should be monitored for early signs of the problem during routine medical visits.
Web Search powered by YAHOO!
|
LifestylesLifestyles
FDA liver risk warning for Bristol-Myers HIV drug
WASHINGTON (AP) - Federal health officials are warning an HIV drug comes with the risk of a rare, but potentially deadly liver disorder.
By:
|
WNCT
Published: February 02, 2010
Published: February 02, 2010
Email
Facebook
Google
Twitter
Favorites
MoreAdvertisement
View More:
Bristol-Myers Squibb,
Disorder,
Food And Drug Administration,
Health_Medical_Pharma,
Hiv,
Liver Disorder,
Liver Failure,
Social Issues,
Videx,
Washington
Not what you're looking for? Try our quick search:
Reader Comments
*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.Deal of the Day
Advertisement
Interactive Radar
Advertisement
Featured Blogger
Reel Reviews
Updated: 02/10/2012
Nine On Your Side's Phillip Sayblack shares his take on the latest movie and dvd releases.
More Posts by Reel Reviews
Hot Topics on WNCT.com
Advertisement
Advertisement